Browse the latest research summaries in the field of oncology for spinal cord injury patients and caregivers.
Showing 1-10 of 144 results
The Journal of Spinal Cord Medicine, 2024 • January 1, 2024
This retrospective study analyzed data from 40 patients with Metastatic Spinal Cord Compression (MSCC) admitted to a specialist spinal cord injury rehabilitation center between 2013 and 2021. The stud...
KEY FINDING: Patients with MSCC showed a significant improvement in Spinal Cord Independence Measure (SCIM) scores after a six-week inpatient rehabilitation program.
Asian Spine Journal, 2023 • April 1, 2023
The study evaluated postoperative functional status using FIM-L, WISCI II, ASIA-LEMS, and ASIA-LESS scores, finding that independent walkers at 2 weeks had better lower-limb and sensory function recov...
KEY FINDING: 71% and 43% of participants were nonindependent ambulators at 1 week and 2 weeks postoperatively, respectively.
International Journal of Surgery Case Reports, 2023 • April 24, 2023
This case report describes a rare complication of TACE, spinal cord ischemia, in a patient with HCC. The patient experienced paraplegia and sensory deficits following the procedure. The etiology is hy...
KEY FINDING: A 78-year-old male with chronic hepatitis B and HCC developed acute paraplegia and sensory loss after a second TACE procedure.
Clin Case Rep, 2023 • June 26, 2023
This case report describes a 79-year-old man who presented with tetraplegia secondary to spinal cord compression caused by multiple myeloma affecting the T1 vertebra. The patient underwent surgical de...
KEY FINDING: The patient presented with acute-onset paraplegia secondary to spinal cord compression from a T1 vertebral lesion caused by multiple myeloma.
Frontiers in Endocrinology, 2023 • July 26, 2023
The editorial discusses how bone homeostasis affects tumor bone metastasis, highlighting that bone metastasis is a common complication of malignant tumors, influenced by interactions in the bone micro...
KEY FINDING: Dysregulation of bone remodeling impairs immune cell function, leading to immune evasion and promoting tumor cell survival and growth in the bone.
Frontiers in Endocrinology, 2023 • September 1, 2023
This study developed a nomogram to predict postoperative HRQoL in lung cancer patients with MSCC, using ECOG score, targeted therapy, anxiety score, and number of comorbidities as predictors. The nomo...
KEY FINDING: Four key variables were identified for predicting HRQoL: ECOG score, targeted therapy, anxiety scale, and number of comorbidities.
Am J Phys Med Rehabil, 2024 • March 1, 2024
Spinal tumors, whether primary or metastatic, pose significant risks of debilitating complications; however, timely and comprehensive care can lead to improved patient outcomes. A multidisciplinary ap...
KEY FINDING: Multidisciplinary approach involving physiatrists is effective in managing spinal tumors and mitigating complications.
Cancer Medicine, 2024 • January 1, 2024
This retrospective study investigated the incidence and risk factors of skeletal-related events (SREs) in 146 patients with Ewing sarcoma (EWS) treated at a single institution between 2005 and 2019. T...
KEY FINDING: SREs occurred in 23 patients during the study period, with radiation to the bone and malignant spinal cord compression being the most frequent initial events.
Cureus, 2024 • April 23, 2024
This case report describes the physiotherapy rehabilitation of a 40-year-old male with grade II ependymomas and spinal cord compression, focusing on improving functional recovery and quality of life. ...
KEY FINDING: The patient's motor score in the lower extremity improved from 0/50 to 20/50 on the ASIA Impairment Scale after physiotherapy rehabilitation.
Medicina, 2024 • May 27, 2024
This study aimed to identify factors associated with the discharge destination of patients with bone metastases, finding that spinal cord compression (SCC), hypercalcemia, and functional ambulation ca...
KEY FINDING: Spinal cord compression (SCC) was significantly associated with discharge to a non-home setting (OR 3.37, 95% CI 1.35–8.43).